Department of Industrial Economics and Trade, School of Economics and Finance, Xi'an Jiaotong University, Xi'an, China.
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
Front Public Health. 2022 Jun 15;10:895649. doi: 10.3389/fpubh.2022.895649. eCollection 2022.
In China, the pharmacy departments of most hospitals have changed their main focus from drug procurement and distribution to providing pharmaceutical care services. Various regions of China have successively implemented the pilot Chief Pharmacist System (CPS) to help improve pharmaceutical care services and rational drug use in hospitals. This study was designed to explore the perspectives of pharmacists and government officials on CPS, including the advantages and barriers to the successful implementation of CPS.
A qualitative study, based on semi-structured interviews, was conducted from October 1, 2018 to March 1, 2019. The interview data were gathered from 18 pharmacy staff and government representatives working in five distinct regions of China using purposive sampling. A thematic analysis approach and NVivo version 12 Plus was utilized to code and analysis of all interviews.
Five broad themes were identified: the role of the chief pharmacist; their attitudes toward the CPS; the advantages and results of the CPS; the barriers toward CPS; and their suggestions toward CPS. Most of the participants believed that the chief pharmacist played a vital role in a hospital. Under CPS, the hospital pharmacy department pays more attention to prescription review, medication monitoring, and pharmaceutical consultation. However, an insufficient number of pharmacy personnel, unclear authority, and inadequate salaries were the main barriers to the implementation of the CPS.
The attitudes of most of the participants were found to be positive toward CPS in China. The CPS can enhance the prestige of the hospital pharmacy department, improve the quality of hospital pharmaceutical care services, and promote rational drug use. Nevertheless, certain barriers highlighted in this study should be addressed promptly.
在中国,大多数医院的药剂科已将其工作重点从药品采购和分发转变为提供药学服务。中国各地区相继实施了总药师制度(CPS),以帮助提高医院的药学服务水平和合理用药水平。本研究旨在探讨药师和政府官员对 CPS 的看法,包括 CPS 成功实施的优势和障碍。
本研究采用基于半结构式访谈的定性研究方法,于 2018 年 10 月 1 日至 2019 年 3 月 1 日进行。采用目的抽样法,从中国五个不同地区的 18 名药剂科工作人员和政府代表收集访谈数据。采用主题分析方法和 NVivo 版本 12 Plus 对所有访谈进行编码和分析。
确定了五个广泛的主题:总药师的角色;他们对 CPS 的态度;CPS 的优势和结果;CPS 的障碍;对 CPS 的建议。大多数参与者认为总药师在医院中起着至关重要的作用。在 CPS 下,医院药剂科更加注重处方审核、用药监测和药学咨询。然而,药剂人员数量不足、权限不明确和薪酬不足是 CPS 实施的主要障碍。
大多数参与者对中国的 CPS 持积极态度。CPS 可以提高医院药剂科的威望,提高医院药学服务质量,促进合理用药。然而,本研究中强调的某些障碍应尽快解决。